APX and Revelle Enter Strategic Partnership
The partnership between APX and Revelle aims to help aesthetic practices accelerate growth and productivity.
The partnership between APX and Revelle aims to help aesthetic practices accelerate growth and productivity.
Available in the EU, UK, and Switzerland, the device is designed for in-office preparation of autologous PRP and Fluid-PRF.
Autologous Spray-On Skin Cells are expanding what's possible in reconstructive surgery. By reducing donor skin requirements and supporting faster, more natural healing, the technology is helping surgeons improve both functional and aesthetic outcomes while reshaping the approach to burns, traumatic wounds, and complex reconstruction.